In the mid-20th century, research increasingly linked the physiological reorganization of pregnancy—notably circulatory adaptations and plasma volume expansion—with endocrine regulation and metabolic remodeling that sustained maternal-fetal energy supply and placental transport. Studies foregrounded the clinical management of pregnancy complications within a framework of pharmacologic intervention and risk stratification, with a focus on toxemias, hypertensive disorders, and the broader obstetric implications of anatomical and fetal development variations. The era also saw the integration of pharmacologic approaches, exemplified by diethylstilbestrol, into obstetric practice, signaling a shift toward translational maternal-fetal medicine. Historical Significance: These findings established a cohesive paradigm in which physiological, endocrine, and pharmacologic processes are interdependent determinants of pregnancy outcomes, laying the groundwork for modern maternal-fetal medicine. Foundational work on nutritional teratogenic risk, immune incompatibilities in pregnancy, and fetomaternal transfusion illuminated new diagnostic, preventive, and therapeutic strategies that shaped subsequent teratology, prenatal screening, and risk management. Collectively, these advances bridged basic physiology with clinical intervention and policy considerations, guiding the evolution of obstetric care through the mid-20th century and beyond.